Cite
MLA Citation
Erin M Hall et al.. “Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection.” Journal for immunotherapy of cancer, vol. 9, no. 1, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100127583326.0x00002a